ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Helping Biotechs Overcome 4 Key Challenges

  Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.

• Killing Excel: The Quiet Crisis In Clinical Trials

  Stop relying on spreadsheets for critical clinical trial decisions. Learn how standardizing vendor selection eliminates inefficiencies and protects budgets.

• The Power Of Predictive Analytics In Clinical Trial Design

  Discover how predictive analytics address clinical trial challenges by applying statistical and modeling techniques to current and historical data.

• Parkinson's Disease: Leveraging Wearable DHTs

  Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.

• Clinical Trials In The Age Of Cost Caps

  On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.

• Key CTMS Capabilities To Improve Financial Management

  In clinical research, utilizing your clinical trial management system (CTMS) to its fullest potential can allow for more streamlined financial management, visit management, compliance, patient recruitment, and more. This blog outlines what you should look for in a CTMS to maximize your organization’s return on investment (ROI).

• Modern Decentralized Trials Demand Advanced eClinical Support

  First-generation eClinical systems can create as many challenges as they resolve. A more coherent solution is necessary to ensure data integrity, ease site burdens, and promote greater patient-centricity.

• Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals

  Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.

• How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer Cachexia

  Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.

• Building A Clinical Research AI Governance Framework

  Learn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.